Abstract #4729

PEG-FGF21 Variant Improves Hepatic Steatosis in a Mouse Model of NASH as Determined by Quantitative Water-fat MRI

Haiying Tang¹, Matthew Fronheiser¹, Stephanie Boehm², Adrienne Pena¹, Shorts Andrea¹, Bradley Zinker², John Krupinski², Harold Malone¹, Patrick Chow¹, Edgar Charles¹, Shuyan Du¹, and Wendy Hayes¹

¹Bristol-Myers Squibb, Lawrenceville, NJ, United States, ²Bristol-Myers Squibb, Hopewell, NJ, United States

Non-alcoholic fatty liver disease (NAFLD) ranges from simple fatty liver to steatohepatitis (NASH) to cirrhosis. In the present study, we implemented a water-fat MRI using the gradient-reversal technique to quantify the hepatic proton density fat-fraction (PDFF), for assessment of hepatic steatosis in a diet-induced mouse model of NASH. We compared the quantitative water-fat MRI technique with conventional Dixon method and single-voxel MR spectroscopy (MRS), and correlated the MRI-PDFF with histology and biochemical triglyceride (TG) content. Lastly, the effects of a PEGylated-FGF21 variant (PEG-FGF21v) on hepatic steatosis in the mouse model was evaluated using the water-fat MRI technique.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.